Pictet Asset Management (Switzerland)’s CRISPR Therapeutics CRSP Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | $487K | Hold |
8,674
| – | – | ﹤0.01% | 1255 |
|
|
2023
Q1 | $392K | Hold |
8,674
| – | – | ﹤0.01% | 1355 |
|
|
2022
Q4 | $353K | Sell |
8,674
-27,633
| -76% | -$1.12M | ﹤0.01% | 1403 |
|
|
2022
Q3 | $2.37M | Sell |
36,307
-386,980
| -91% | -$25.3M | ﹤0.01% | 892 |
|
|
2022
Q2 | $25.7M | Buy |
423,287
+419,387
| +10,754% | +$25.5M | 0.04% | 400 |
|
|
2022
Q1 | $245K | Hold |
3,900
| – | – | ﹤0.01% | 1454 |
|
|
2021
Q4 | $296K | Hold |
3,900
| – | – | ﹤0.01% | 1393 |
|
|
2021
Q3 | $437K | Buy |
+3,900
| New | +$437K | ﹤0.01% | 1244 |
|